Table 2. Therapy-related adverse events.
Therapy-related adverse events
| Category | Toxicity | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Total | % |
|---|---|---|---|---|---|---|---|
| Constitutional | Fatigue | 4 | 1 | 5 | 21% | ||
| Dizzyness | 1 | 1 | 4% | ||||
| Anorexia | 1 | 1 | 4% | ||||
| Chills | 1 | 1 | 4% | ||||
| Hematologic | Leukopenia | 1 | 1 | 4% | |||
| Low Platelet | 1 | 1 | 4% | ||||
| Dermatologic | Site Reaction | 9 | 9 | 38% | |||
| Dry skin | 2 | 2 | 8% | ||||
| Edema: limb | 1 | 1 | 4% | ||||
| GI | Diarrhea | 3 | 1 | 4 | 17% | ||
| Nausea | 4 | 2 | 1 | 7 | 29% | ||
| ALT elevation | 1 | 1 | 4% | ||||
| Pain | Headache | 7 | 3 | 3 | 13 | 54% | |
| Joint pain | 1 | 1 | 4% | ||||
| Abdomen pain | 1 | 1 | 4% | ||||
| Injection pain | 1 | 1 | 4% |
Includes all definite, probable, and possible attributions. Common toxicity criteria (CTC) version 3.0. GI: gastroenterological. ALT: alanine aminotransferase.